» Articles » PMID: 8514066

The Non-bleeding Visible Vessel Versus the Sentinel Clot: Natural History and Risk of Rebleeding

Overview
Date 1993 May 1
PMID 8514066
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Non-bleeding visible vessel and sentinel clot are terms used interchangeably to describe protuberances in the base of ulcers that have recently bled, but a consensus as to their definition or natural history does not exist. In patients with severe ulcer hemorrhage, non-bleeding protuberances were classified as vessels, with or without a small attached clot, or as sentinel clots, according to a schema based on the appearance of the protuberance at endoscopy but not subjected to pathologic correlation. Endoscopic therapy was not performed at the index endoscopic evaluation, and natural evolution was prospectively documented with daily videoendoscopy. Eleven (46%) of 24 patients with non-bleeding protuberances had rebleeding. Independent classification by three authors concurred in 18 (75%) of 24 lesions. Ten (91%) of 11 vessels with or without attached clot rebled versus 0 (0%) of 7 sentinel clots and 1 (17%) of 6 lesions without unanimous classification (p < 0.01, vessels versus other groups). Rebleeding occurred in 5 (71%) of 7 nonpigmented (pale or white), 6 (38%) of 16 red or purple, and 0 (0%) of 1 black protuberances. In general, vessels persisted until rebleeding, whereas sentinel clots disappeared within 1 to 3 days. We conclude that nonbleeding protuberances in ulcer bases can be separated into vessels, which have a high risk of rebleeding, and sentinel clots, which have a low risk of rebleeding.

Citing Articles

Doppler endoscopic probe as a guide to risk stratification and definitive hemostasis of peptic ulcer bleeding.

Jensen D, Ohning G, Kovacs T, Ghassemi K, Jutabha R, Dulai G Gastrointest Endosc. 2015; 83(1):129-36.

PMID: 26318834 PMC: 4691549. DOI: 10.1016/j.gie.2015.07.012.


A real world report on intravenous high-dose and non-high-dose proton-pump inhibitors therapy in patients with endoscopically treated high-risk peptic ulcer bleeding.

Lu L, Lin S, Kuo C, Tai W, Tseng P, Chang K Gastroenterol Res Pract. 2012; 2012:858612.

PMID: 22844276 PMC: 3403596. DOI: 10.1155/2012/858612.


Endoscopic therapy for peptic ulcer hemorrhage: practice variations in a multi-center U.S. consortium.

Enestvedt B, Gralnek I, Mattek N, Lieberman D, Eisen G Dig Dis Sci. 2010; 55(9):2568-76.

PMID: 20585979 PMC: 3922223. DOI: 10.1007/s10620-010-1311-5.


Endoscopic Doppler ultrasound versus endoscopic stigmata-directed management of acute peptic ulcer hemorrhage: a multimodel cost analysis.

Chen V, Wong R Dig Dis Sci. 2006; 52(1):149-60.

PMID: 17109216 DOI: 10.1007/s10620-006-9506-5.


A practical guide to the management of bleeding ulcers.

Villanueva C, Balanzo J Drugs. 1997; 53(3):389-403.

PMID: 9074841 DOI: 10.2165/00003495-199753030-00004.